Europe Self-Monitoring Blood Glucose Devices Market Size By Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets), By End-User (Hospitals, Home Settings, Diagnostic Centers & Clinics), Industry Analysis Report, Regional Outlook (Germany, UK, France, Spain, Italy, Russia, Ukraine, Poland, Switzerland, Belgium, Greece, Czech Republic, Netherlands, Sweden), End-User Potential, Competitive Market Share & Forecast, 2018 – 2024

Published Date: August 2018 | Publisher: Graphical Research Report ID: GR1020 | Delivery : PDF

Report Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1.  Secondary

1.4.1.1.  Paid sources

1.4.1.2.    Unpaid sources       

1.4.2.  Primary

Chapter 2. Executive Summary

2.1. Europe self-monitoring blood glucose devices industry 3600 synopsis, 2013 - 2024

Chapter 3. Europe Self-Monitoring Blood Glucose Devices Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 – 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1.  Rising prevalence of diabetes in Europe

3.3.1.2.    Technological advancement in SMBG devices

3.3.1.3.    Government initiatives for increasing awareness among people

3.3.2. Industry pitfalls & challenges

3.3.2.1.  High cost associated with SMBG devices and accessories

3.3.2.2.    Lack of reimbursement & stringent regulations for SMBG devices

3.4. Growth potential analysis

3.4.1.  By product

3.4.2.  By end-user

3.5. Competitive landscape, 2017

3.5.1.  Strategy dashboard

3.6. Porter’s analysis

3.7. PESTEL analysis

Chapter 4.  Europe Self-Monitoring Blood Glucose Devices Market, By Product

4.1. Key segment trends

4.2. Self-monitoring blood glucose meters

4.2.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

4.3. Continuous glucose monitors

4.3.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

4.4. Testing strips

4.4.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

4.5. Lancets

4.5.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

Chapter 5. Europe Self-Monitoring Blood Glucose Devices Market, By End-user

5.1. Key segment trends

5.2. Hospitals

5.2.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

5.3. Home settings

5.3.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

5.4. Diagnostic centers and clinics

5.4.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

Chapter 6. Europe Self-Monitoring Blood Glucose Devices Market, By Country

6.1. Key regional trends

6.2. Europe

6.2.1.  Market size, by country, 2013 – 2024(USD Million)

6.2.2.  Market size, by product, 2013 – 2024(USD Million)

6.2.3.  Market size, by end-user, 2013 – 2024(USD Million)

6.2.4.  Germany

6.2.4.1.  Market size, by product, 2013 – 2024(USD Million)

6.2.4.2.    Market size, by end-user, 2013 – 2024(USD Million)

6.2.5.  UK

6.2.5.1.  Market size, by product, 2013 – 2024(USD Million)

6.2.5.2.    Market size, by end-user, 2013 – 2024(USD Million)

6.2.6.  France

6.2.6.1.  Market size, by product, 2013 – 2024(USD Million)

6.2.6.2.    Market size, by end-user, 2013 – 2024(USD Million)

6.2.7.  Spain

6.2.7.1.  Market size, by product, 2013 – 2024(USD Million)

6.2.7.2.    Market size, by end-user, 2013 – 2024(USD Million)

6.2.8.  Italy

6.2.8.1.  Market size, by product, 2013 – 2024(USD Million)

6.2.8.2.    Market size, by end-user, 2013 – 2024(USD Million)

6.2.9.  Russia

6.2.9.1.  Market size, by product, 2013 – 2024(USD Million)

6.2.9.2.    Market size, by end-user, 2013 – 2024(USD Million)

6.2.10. Ukraine

6.2.10.1.  Market size, by product, 2013 – 2024(USD Million)

6.2.10.2.  Market size, by end-user, 2013 – 2024(USD Million)

6.2.11. Poland

6.2.11.1.  Market size, by product, 2013 – 2024(USD Million)

6.2.11.2.  Market size, by end-user, 2013 – 2024(USD Million)

6.2.12. Switzerland

6.2.12.1.  Market size, by product, 2013 – 2024(USD Million)

6.2.12.2.  Market size, by end-user, 2013 – 2024(USD Million)

6.2.13. Belgium

6.2.13.1.  Market size, by product, 2013 – 2024(USD Million)

6.2.13.2.  Market size, by end-user, 2013 – 2024(USD Million)

6.2.14. Greece

6.2.14.1.  Market size, by product, 2013 – 2024(USD Million)

6.2.14.2.  Market size, by end-user, 2013 – 2024(USD Million)

6.2.15. Czech Republic

6.2.15.1.  Market size, by product, 2013 – 2024(USD Million)

6.2.15.2.  Market size, by end-user, 2013 – 2024(USD Million)

6.2.16. Netherlands

6.2.16.1.  Market size, by product, 2013 – 2024(USD Million)

6.2.16.2.  Market size, by end-user, 2013 – 2024(USD Million)

6.2.17. Sweden

6.2.17.1.  Market size, by product, 2013 – 2024(USD Million)

6.2.17.2.  Market size, by end-user, 2013 – 2024(USD Million)

Chapter 7. Company Profiles

7.1. Abbott Laboratories

7.1.1.  Business overview

7.1.2.  Financial data

7.1.3.  Product landscape

7.1.4.  Strategic outlook

7.2. All Medicus

7.2.1.  Business overview

7.2.2.  Financial data

7.2.3.  Product landscape

7.2.4.  Strategic outlook

7.3. Arkray

7.3.1.  Business overview

7.3.2.  Financial data

7.3.3.  Product landscape

7.3.4.  Strategic outlook

7.4. B. Braun Melsungen AG

7.4.1.  Business overview

7.4.2.  Financial data

7.4.3.  Product landscape

7.4.4.  Strategic outlook

7.5. Bayer Healthcare

7.5.1.  Business overview

7.5.2.  Financial data

7.5.3.  Product landscape

7.5.4.  Strategic outlook

7.6. Bionime Corporation

7.6.1.  Business overview

7.6.2.  Financial data

7.6.3.  Product landscape

7.6.4.  Strategic outlook

7.7. Dexcom

7.7.1.  Business overview

7.7.2.  Financial data

7.7.3.  Product landscape

7.7.4.  Strategic outlook

7.8. F. Hoffmann-La Roche

7.8.1.  Business overview

7.8.2.  Financial data

7.8.3.  Product landscape

7.8.4.  Strategic outlook

7.9. Johnson & Johnson

7.9.1.   Business overview

7.9.2.  Financial data

7.9.3.  Product landscape

7.9.4.  Strategic outlook

7.10.  LifeScan

7.10.1. Business overview

7.10.2.    Financial data

7.10.3.    Product landscape

7.10.4.    Strategic outlook

7.11.  Medtronic

7.11.1. Business overview

7.11.2.    Financial data

7.11.3.    Product landscape

7.11.4.    Strategic outlook

7.12.  Nipro Diagnostics

7.12.1. Business overview

7.12.2.    Financial data

7.12.3.    Product landscape

7.12.4.    Strategic outlook

7.13.  Nova Biomedical

7.13.1. Business overview

7.13.2.    Financial data

7.13.3.    Product landscape

7.13.4.    Strategic outlook

7.14.  Sinocare

7.14.1. Business overview

7.14.2.    Financial data

7.14.3.    Product landscape

7.14.4.    Strategic outlook

7.15.  Trividia Health

7.15.1. Business overview

7.15.2.    Financial data

7.15.3.    Product landscape

7.15.4.    Strategic outlook
 

Data Tables

TABLE 1.  Europe self-monitoring blood glucose devices industry 360° synopsis, 2013 – 2024       

TABLE 2.   Industry impact forces

TABLE 3.   Self-monitoring blood glucose meters market size, by country, 2013 – 2024 (USD Million)

TABLE 4.   Continuous glucose monitors market size, by country, 2013 – 2024 (USD Million)

TABLE 5.   Testing strips market size, by country, 2013 – 2024 (USD Million)

TABLE 6.   Lancets market size, by country, 2013 – 2024 (USD Million)

TABLE 7.   Hospitals market size, by country, 2013 – 2024 (USD Million)

TABLE 8.   Home settings market size, by country, 2013 – 2024 (USD Million)

TABLE 9.   Diagnostic centers and clinics market size, by country, 2013 – 2024 (USD Million)

TABLE 10.   Europe self-monitoring blood glucose devices market size, by country, 2013-2024 (USD Million)

TABLE 11.   Europe self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 12.   Europe self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 13.   Germany self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 14.   Germany self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 15.   UK self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 16.   UK self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 17.   France self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 18.   France self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 19.   Spain self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 20.   Spain self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 21.   Italy self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 22.   Italy self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 23.   Russia self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 24.   Russia self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 25.   Ukraine self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 26.   Ukraine self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 27.   Poland self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 28.   Poland self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 29.   Switzerland self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 30.   Switzerland self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 31.   Belgium self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 32.   Belgium self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 33.   Greece self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 34.   Greece self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 35.   Czech Republic self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 36.   Czech Republic self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 37.   Netherlands self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 38.   Netherlands self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 39.   Sweden self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 40.   Sweden self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)
 

Charts & Figures

FIG. 1   Industry segmentation

FIG. 2   Europe self-monitoring blood glucose devices market, 2013 - 2024 (USD Million)

FIG. 3   Growth potential analysis, by product

FIG. 4   Growth potential analysis, by end-user

FIG. 5   Strategy dashboard

FIG. 6   Porter’s analysis

FIG. 7   PESTEL analysis

 

 

Select License

Europe Self-Monitoring Blood Glucose Devices Market Forecast 2024


Related Reports
Why Choose us?